These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 24623318)
1. The flavonols quercetin and 3',4'-dihydroxyflavonol reduce platelet function and delay thrombus formation in a model of type 1 diabetes. Mosawy S; Jackson DE; Woodman OL; Linden MD Diab Vasc Dis Res; 2014 May; 11(3):174-81. PubMed ID: 24623318 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of platelet-mediated arterial thrombosis and platelet granule exocytosis by 3',4'-dihydroxyflavonol and quercetin. Mosawy S; Jackson DE; Woodman OL; Linden MD Platelets; 2013; 24(8):594-604. PubMed ID: 23249183 [TBL] [Abstract][Full Text] [Related]
3. Treatment with quercetin and 3',4'-dihydroxyflavonol inhibits platelet function and reduces thrombus formation in vivo. Mosawy S; Jackson DE; Woodman OL; Linden MD J Thromb Thrombolysis; 2013 Jul; 36(1):50-7. PubMed ID: 23070586 [TBL] [Abstract][Full Text] [Related]
4. 3',4'-Dihydroxyflavonol restores endothelium-dependent relaxation in small mesenteric artery from rats with type 1 and type 2 diabetes. Leo CH; Hart JL; Woodman OL Eur J Pharmacol; 2011 Jun; 659(2-3):193-8. PubMed ID: 21453697 [TBL] [Abstract][Full Text] [Related]
5. Vascular and anti-oxidant actions of flavonols and flavones. Woodman OL; Chan ECh Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):786-90. PubMed ID: 15566394 [TBL] [Abstract][Full Text] [Related]
6. Acid sphingomyelinase regulates platelet cell membrane scrambling, secretion, and thrombus formation. Münzer P; Borst O; Walker B; Schmid E; Feijge MA; Cosemans JM; Chatterjee M; Schmidt EM; Schmidt S; Towhid ST; Leibrock C; Elvers M; Schaller M; Seizer P; Ferlinz K; May AE; Gulbins E; Heemskerk JW; Gawaz M; Lang F Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):61-71. PubMed ID: 24233488 [TBL] [Abstract][Full Text] [Related]
7. Pentamethylquercetin (PMQ) reduces thrombus formation by inhibiting platelet function. Liang ML; Da XW; He AD; Yao GQ; Xie W; Liu G; Xiang JZ; Ming ZY Sci Rep; 2015 Jun; 5():11142. PubMed ID: 26059557 [TBL] [Abstract][Full Text] [Related]
8. 3',4'-Dihydroxyflavonol prevents diabetes-induced endothelial dysfunction in rat aorta. Woodman OL; Malakul W Life Sci; 2009 Jul; 85(1-2):54-9. PubMed ID: 19409910 [TBL] [Abstract][Full Text] [Related]
9. Modulation of nicotinamide adenine dinucleotide phosphate oxidase expression and function by 3',4'-dihydroxyflavonol in phagocytic and vascular cells. Jiang F; Guo N; Dusting GJ J Pharmacol Exp Ther; 2008 Jan; 324(1):261-9. PubMed ID: 17916758 [TBL] [Abstract][Full Text] [Related]
10. Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis. Momi S; Caracchini R; Falcinelli E; Evangelista S; Gresele P Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):820-9. PubMed ID: 24558107 [TBL] [Abstract][Full Text] [Related]
11. Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans. Hubbard GP; Wolffram S; Lovegrove JA; Gibbins JM J Thromb Haemost; 2004 Dec; 2(12):2138-45. PubMed ID: 15613018 [TBL] [Abstract][Full Text] [Related]
12. Effects of quercetin on aggregation and intracellular free calcium of platelets. Xiao D; Gu ZL; Bai JP; Wang Z Zhongguo Yao Li Xue Bao; 1995 May; 16(3):223-6. PubMed ID: 7660815 [TBL] [Abstract][Full Text] [Related]
13. Platelets possess and require an active protein palmitoylation pathway for agonist-mediated activation and in vivo thrombus formation. Sim DS; Dilks JR; Flaumenhaft R Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1478-85. PubMed ID: 17303775 [TBL] [Abstract][Full Text] [Related]
14. Effect of chronic treatment with acetylsalicylic acid and clopidogrel on atheroprogression and atherothrombosis in ApoE-deficient mice in vivo. Schulz C; Konrad I; Sauer S; Orschiedt L; Koellnberger M; Lorenz R; Walter U; Massberg S Thromb Haemost; 2008 Jan; 99(1):190-5. PubMed ID: 18217153 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of Bulnesia sarmienti aqueous extract on agonist-induced platelet activation and thrombus formation involves mitogen-activated protein kinases. Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim KS; Hong JH; Kwak YS; Yun BS; Rhee MH J Ethnopharmacol; 2010 Aug; 130(3):614-20. PubMed ID: 20558266 [TBL] [Abstract][Full Text] [Related]
16. Neferine exerts its antithrombotic effect by inhibiting platelet aggregation and promoting dissociation of platelet aggregates. Zhou YJ; Xiang JZ; Yuan H; Liu H; Tang Q; Hao HZ; Yin Z; Wang J; Ming ZY Thromb Res; 2013 Aug; 132(2):202-10. PubMed ID: 23773522 [TBL] [Abstract][Full Text] [Related]
17. Prevention of occlusive arterial thrombus formation by a single loading dose of prasugrel suppresses neointimal hyperplasia in mice. Ohno K; Tomizawa A; Jakubowski JA; Mizuno M; Sugidachi A Thromb Res; 2015 Dec; 136(6):1245-51. PubMed ID: 26489728 [TBL] [Abstract][Full Text] [Related]
18. Tangeretin regulates platelet function through inhibition of phosphoinositide 3-kinase and cyclic nucleotide signaling. Vaiyapuri S; Ali MS; Moraes LA; Sage T; Lewis KR; Jones CI; Gibbins JM Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2740-9. PubMed ID: 24135020 [TBL] [Abstract][Full Text] [Related]